Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q1

3353.TEDINET S100OPR7
Period2022-03-01 → 2022-05-31
Filed2022-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.6bn2022-03-01 → 2022-05-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥8.5bn2021-03-01 → 2021-05-31Cons.Net sales
Operating income¥239m2022-03-01 → 2022-05-31Cons.Operating income
Operating income¥303m2021-03-01 → 2021-05-31Cons.Operating income
Ordinary income¥313m2022-03-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥316m2021-03-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥334m2022-03-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥386m2021-03-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥208m2022-03-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥226m2021-03-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥213m2022-03-01 → 2022-05-31Cons.Profit loss
Net income¥226m2021-03-01 → 2021-05-31Cons.Profit loss
Total assets¥28.8bnat 2022-05-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥28.3bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥16.8bnat 2022-05-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥10.6bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2022-05-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
EPS (basic)¥55.392022-03-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.092021-03-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio39.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio37.5%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-05-31−¥189m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-05-31¥363m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-05-31¥19m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-05-31¥946m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-05-31¥694m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥252m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-05-31¥16m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥381,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-05-31¥30m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-05-31¥8.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-05-31¥253m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-05-31¥428m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-05-31−¥180m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-05-31¥340m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-05-31¥74m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-05-31¥1.0bn
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-05-31¥726m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥278m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-05-31¥36m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-05-31¥59m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-05-31¥58m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥540,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-05-31¥33m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-05-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-05-31¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-05-31¥483m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 353
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant313900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant313900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0771
Cash and depositsPrior1YearInstant7992461000JPY
Cash and depositsCurrentQuarterInstant7340497000JPY
Accounts receivable tradePrior1YearInstant4890612000JPY
Accounts receivable tradeCurrentQuarterInstant5012213000JPY
MerchandisePrior1YearInstant1214011000JPY
MerchandiseCurrentQuarterInstant1319731000JPY
Other caPrior1YearInstant482691000JPY
Other caCurrentQuarterInstant721438000JPY
Allowance for doubtful accounts caPrior1YearInstant-2288000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-2388000JPY
Current assetsPrior1YearInstant14577486000JPY
Current assetsCurrentQuarterInstant14391492000JPY
Buildings and structures netPrior1YearInstant5825315000JPY
Buildings and structures netCurrentQuarterInstant5729542000JPY
LandPrior1YearInstant3739216000JPY
LandCurrentQuarterInstant3739216000JPY
Other net ppePrior1YearInstant299973000JPY
Other net ppeCurrentQuarterInstant327359000JPY
Property plant and equipmentPrior1YearInstant9864505000JPY
Property plant and equipmentCurrentQuarterInstant9796118000JPY
GoodwillPrior1YearInstant1536222000JPY
GoodwillCurrentQuarterInstant1479389000JPY
Other iaPrior1YearInstant177185000JPY
Other iaCurrentQuarterInstant174825000JPY
Intangible assetsPrior1YearInstant1713408000JPY
Intangible assetsCurrentQuarterInstant1654214000JPY
Investment securitiesPrior1YearInstant1104507000JPY
Investment securitiesCurrentQuarterInstant1077303000JPY
Lease and guarantee depositsPrior1YearInstant906042000JPY
Lease and guarantee depositsCurrentQuarterInstant936426000JPY
Other ioaPrior1YearInstant928306000JPY
Other ioaCurrentQuarterInstant965904000JPY
Investments and other assetsPrior1YearInstant2938856000JPY
Investments and other assetsCurrentQuarterInstant2979634000JPY
Noncurrent assetsPrior1YearInstant14516769000JPY
Noncurrent assetsCurrentQuarterInstant14429967000JPY
AssetsPrior1YearInstant29094256000JPY
AssetsCurrentQuarterInstant28821459000JPY
Notes payable tradePrior1YearInstant46847000JPY
Notes payable tradeCurrentQuarterInstant46315000JPY
Accounts payable tradePrior1YearInstant3434630000JPY
Accounts payable tradeCurrentQuarterInstant3728751000JPY
Short term loans payablePrior1YearInstant170000000JPY
Short term loans payableCurrentQuarterInstant270000000JPY
Current portion of long term loans payablePrior1YearInstant3562395000JPY
Current portion of long term loans payableCurrentQuarterInstant3398134000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-05-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-05-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass